From December 29 to 31, 2025, The United Laboratories (Inner Mongolia) Co., Ltd. completed the production license and GMP compliance inspection for its new production line of clavulanate potassium and its blends. The successful completion of this inspection marks a critical step in the company's expansion of API production capacity, optimization of product mix, and quality assurance capabilities, providing solid support for the company to further expand into the high-end antibiotic market and meet diverse customer needs at home and abroad.